Methylenetetrahydrofolate reductase C677T polymorphism in patients with Henoch-Schönlein purpura

Pediatrics International

Volumn 53, Issue 3, 2011, Pages 358-362

  Emre, Sevinc ^a   Sirin, Aydan ^a   Ergen, Arzu ^b   Bilge, Ilmay ^a   Sucu, Aysegul ^a   Yilmaz, Alev ^a   Isbir, Turgay ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Institute for Experimental Medicine Research   (Turkey)

Author keywords

children; gene; Henoch Sch nlein purpura; methylenetetrahydrofolate reductase; MTHFR; polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ANAPHYLACTOID PURPURA; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; FOCAL GLOMERULOSCLEROSIS; GEL ELECTROPHORESIS; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PURPURA, SCHOENLEIN-HENOCH;

EID: 79959703983     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03247.x     Document Type: Article

References (28)

1. Davin J-C, Weening JJ,. Henoch-Schönlein purpura nephritisi an update. Eur. J. Pediatr. 2001; 160: 689-95.
2. Tsukahara H, Hiraoka M, Saito M, et al,. Methylentetrahydrofolate reductase polymorphism in Kawasaki disease. Pediatr. Int. 2000; 42: 236-40. (Pubitemid 30409335)
3. Ray JG, Shmorgan D, Chan WS,. Common C677T polymorphism of the methylentetra hydrofolate reductase gene and the risk of venous tromboembolism: Meta analysis of 31 studies. Pathophysiol. Haemost. Tromb. 2002; 32: 51-8. (Pubitemid 37490507)
4. Almawi WY, Tamim H, Kreidy R, et al,. A case control study on the contribution of factor V-leiden, prothrombin G 20210A and MTHFR C677T mutations to the genetic susceptibility of deep venous trombosis. J. Thromb. Thrombolysis 2005; 19: 189-96. (Pubitemid 41149481)
5. Fletcher O, Kessling AM,. MTHFR association with arteriosclerotic vascular disease? Hum. Genet. 1998; 103: 11-21. (Pubitemid 28398379)
6. Yilmaz H, Isbir S, Agachan B, Ergen A, Farsak B,. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease. Cell Biochem. Funct. 2006; 24: 87-90. (Pubitemid 43171012)
7. Kalina A, Czeizel AE,. The methylene tetrahydrofolate reductase gene polymorphism (C677T) is associated with increased cardiovascular mortality in Hungary. Int. J. Cardiol. 2004; 97: 333-4. (Pubitemid 39286862)
8. Pinto X, Vilaseca MA, Garcia-Giralt N, et al,. Homocysteine and the MTHFR C677T allele in premature coronary artery disease. Case control and family studies. Eur. J. Clin. Invast. 2001; 31: 24-30. (Pubitemid 32151118)
9. Kawamoto R, Kohara K, Tabara Y, Miki T, Doi T,. An association of 9,10-methylenetetra hydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis. J. Hum. Genet. 2001; 46: 506-10. (Pubitemid 32847564)
10. Lievers KJ, Boers GH, Verhoef P, et al,. A second common variant in the methylene tetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme, activity, homocysteine and cardiovascular disease risk. J. Mol. Med. 2001; 79: 522-8. (Pubitemid 32905549)
11. Yilmaz H, Agachan B, Ergen A, Karaali ZA, Isbir T,. Methylene tetrahydrosel C677T mutation and left venticular hypertrophy in Turkish patients with type II diabetes mellitus. J. Biochem. Mol. Biol. 2004; 37: 234-8. (Pubitemid 38608879)
12. Moczulski D, Fojcik H, Zukowska Szczechowska E, Szydlowska I, Grzeszczak W,. Effects of the C677T and A 1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol. Dial. Transplant. 2003; 18: 1535-40. (Pubitemid 36939625)
13. Hasegawa G, Obayasi H, Kamiuchi K, et al,. The association between end stage diabetic nephropathy and methylene tetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 2003; 11: 132-8. (Pubitemid 36682051)
14. Zou C, Tsukahara H, Hiraoka M, Mizu J, Todoraki Y,. Methylenetetrahydrofolate reductase polymorphism in childhood primary focal segmental glomerulosclerosis. Nephron 2002; 92: 449-51. (Pubitemid 35316894)
15. 12 levels, and C677T MTHFR mutation in children with renal failure. Pediatr. Nephron. 2003; 18: 225-9. (Pubitemid 36790045)
16. Lim PS, Hung WR, Wei YH,. Polymorphism in methylentetrahydrofolate reductase gene: Its impact on plasma homocysteine levels and carotid atherosklerosis in ESRD patients receiving hemodialysis. Nephron 2001; 87: 249-56.
17. Merouani A, Lambert M, Delvin EE, Genest J, Robitaille P,. Plasma homocysteine concentration in children with chronic renal failure. Pediatr. Nephrol. 2001; 16: 805-11. (Pubitemid 32895609)
18. Zychma MJ, Gumprecht J, Grzeszczak W, Zukowska-Szczechowska E,. Methylenetetrahydrofolate reductase gene C677T polymorphism plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients. Nephron 2002; 92: 235-9. (Pubitemid 34983904)
19. Dagan E, Brik R, Broza Y, Gershoni-Baruch R,. Henoch-Schönlein purpura: Polymorphisms in trombophilia genes. Ped. Nephrol. 2006; 21: 1117-21. (Pubitemid 44083884)
20. Miner S, Evrovsk J, Cole DC,. Clinical Chemistry and molecular biology of homocysteine metabolism: An update. Clin. Biochem. 1997; 30: 189-201. (Pubitemid 27225351)
21. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE,. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci. 2001; 22: 195-201. (Pubitemid 32244306)
22. Frosst P, Blom HJ, Milos R, Goyette P, Shephard CA,. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydro folate reductase. Nat. Genet. 1995; 10: 111-13.
23. Ozen S, Ruperto N, Dillon MJ, et al,. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann. Rheum. Dis. 2006; 65: 936-41; Epub 2005 Dec 1.
24. White RHR, Yoshikawa N, Feehally J,. IgA nephropathy and Henoch-Schönlein nephritis. In:, Barratt T, Avner ED, Harmon WE, (eds). Pediatric Nephrology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 1999; 691-706.
25. Miller SA, Dykes DD, Polesky HF,. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
26. Jishi AA, Krishnan PR, Almawi WY,. Takayasu Arteritis with high titre of antiphospholipid antibodies and MTHFR polymorphism. J. Thromb. Thrombolysis 2005; 20: 47-50. (Pubitemid 41300622)
27. Rassoul F, Richter V, Hentschel B, Geisel J, Herrmann W, Kuntze T,. Plasma homocysteine levels & 677C→T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity. Indian J. Med. Res. 2008; 127: 154-8. (Pubitemid 351936166)
28. Zak I, Sarecka-Hujar B, Kopyta I, et al,. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J. Child. Neurol. 2009; 24: 1262-7.